Patents by Inventor Joan Sangalang

Joan Sangalang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070275952
    Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Tie-2. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.
    Type: Application
    Filed: March 19, 2004
    Publication date: November 29, 2007
    Applicant: Exelixis, Inc.
    Inventors: Lynne Bannen, S. Brown, Wei Cheng, Vasu Jammalamadaka, John Nuss, Morrison Mac, Jason Parks, Matthew Williams, Wei Xu, Atwood Cheung, Lisa Dalrymple, Sergey Epshteyn, Mohamed Ibrahim, James Leahy, Gary Lewis, Robin Noguchi, Larry Mann, Brian Ridway, Joan Sangalang, Kevin Schnepp, Xian Shi, Richard Khoury
  • Publication number: 20070161651
    Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Tie-2. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.
    Type: Application
    Filed: April 8, 2004
    Publication date: July 12, 2007
    Applicant: EXELIXIS, INC.
    Inventors: Mohamed Ibrahim, James Leahy, Joan Sangalang, Kevin Schnepp, Xian Shi, John Nuss
  • Publication number: 20060293342
    Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Tie-2. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.
    Type: Application
    Filed: April 8, 2004
    Publication date: December 28, 2006
    Applicant: EXELIXIS, INC.
    Inventors: Jeff Chen, Lisa Dalrymple, Sergey Epshteyn, Timothy Forsyth, Tai Huynh, James Leahy, Brian Ridgway, Grace Mann, Larry Mann, Craig Takeuchi, Joan Sangalang